Hai Huang

The First Affiliated Hospital, Zhejian Guniversity School of Medncine, Hangzhou, 310009, Zhejiang, China
Author    Correspondence author
International Journal of Clinical Case Reports, 2024, Vol. 14, No. 5   
Received: 17 Aug., 2024    Accepted: 25 Sep., 2024    Published: 29 Oct., 2024

This is an open access article published under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

The report explores the latest advancements in the field of lung cancer radiotherapy, focusing on cutting-edge technologies and their clinical significance. It discusses the development of stereotactic body radiotherapy (SBRT), intensity-modulated radiotherapy (IMRT), and proton therapy, highlighting their effectiveness in improving tumor control rates while reducing toxicity. Emerging technologies, such as FLASH radiotherapy, are also mentioned, demonstrating their potential to further revolutionize treatment by minimizing damage to healthy tissues. The integration of radiotherapy with systemic therapies, including immunotherapy, has shown synergistic effects, enhancing both local and systemic tumor control. Personalized radiotherapy, based on biomarkers and genomic analysis, is emphasized, showcasing the potential to tailor treatments according to individual patient and tumor characteristics. The report also addresses challenges related to accessibility and cost-effectiveness, particularly in resource-limited settings, and provides recommendations for future research to optimize clinical outcomes and expand access to innovative therapies.

Radiotherapy innovations; Lung cancer; SBRT; FLASH radiotherapy; Personalized medicine